Literature DB >> 17699501

Peripheral arterial disease: a guide for nephrologists.

Stephanie S DeLoach1, Emile R Mohler.   

Abstract

Cardiovascular disease is a major source of morbidity and mortality for patients with chronic kidney disease (CKD). Peripheral arterial disease (PAD) is a strong predictor of coronary artery disease and a risk factor for mortality in the general population. This is of particular interest to nephrologists because the risk for PAD is increased in CKD. Often, PAD is overlooked as a source of morbidity and as a cardiovascular risk factor in this population. This review serves as an overview of the epidemiology, screening, diagnosis, and treatment of PAD with an emphasis on CKD.

Entities:  

Mesh:

Year:  2007        PMID: 17699501     DOI: 10.2215/CJN.04101206

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  13 in total

1.  Anti-PF4/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients.

Authors:  Yueh-Feng Tsai; Chien-An Chen; Chieh Kuo; Kao-Chang Lin
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

2.  Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients.

Authors:  James B Wetmore; Jonathan D Mahnken; Purna Mukhopadhyay; Qingjiang Hou; Edward F Ellerbeck; Sally K Rigler; John A Spertus; Theresa I Shireman
Journal:  Am J Kidney Dis       Date:  2011-05-31       Impact factor: 8.860

3.  Prevalence of risk factors for foot ulceration in a general haemodialysis population.

Authors:  Nia J Jones; James Chess; Scott Cawley; Aled O Phillips; Stephen G Riley
Journal:  Int Wound J       Date:  2012-08-14       Impact factor: 3.315

4.  Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease.

Authors:  Jing Chen; Emile R Mohler; Dawei Xie; Michael Shlipak; Raymond R Townsend; Lawrence J Appel; Akinlolu Ojo; Martin Schreiber; Lisa Nessel; Xiaoming Zhang; Dominic Raj; Louise Strauss; Claudia M Lora; Mahboob Rahman; L Lee Hamm; Jiang He
Journal:  Nephrol Dial Transplant       Date:  2015-12-18       Impact factor: 5.992

5.  Risk factors for peripheral arterial disease among patients with chronic kidney disease.

Authors:  Jing Chen; Emile R Mohler; Dawei Xie; Michael G Shlipak; Raymond R Townsend; Lawrence J Appel; Dominic S Raj; Akinlolu O Ojo; Martin J Schreiber; Louise F Strauss; Xiaoming Zhang; Xin Wang; Jiang He; L Lee Hamm
Journal:  Am J Cardiol       Date:  2012-03-31       Impact factor: 2.778

6.  Anti-platelet factor 4/heparin antibody is associated with progression of peripheral arterial disease in hemodialysis patients.

Authors:  Yen-Hsun Chen; Kao-Chang Lin; Yueh-Feng Tsai; Lai-King Yu; Li-Hsueh Huang; Chien-An Chen
Journal:  Int Urol Nephrol       Date:  2015-07-22       Impact factor: 2.370

7.  Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patients.

Authors:  Hiroaki Ogata; Chiaki Kumata-Maeta; Kanji Shishido; Masahide Mizobuchi; Masahiro Yamamoto; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-26       Impact factor: 8.237

8.  Serum ferritin is associated with progression of peripheral arterial disease in hemodialysis patients.

Authors:  Chen-Tung Lien; Kao-Chang Lin; Yueh-Feng Tsai; Lai-King Yu; Li-Hsueh Huang; Chien-An Chen
Journal:  Clin Exp Nephrol       Date:  2014-12-24       Impact factor: 2.801

9.  The association of biomarkers of iron status with peripheral arterial disease in US adults.

Authors:  Andy Menke; José Manuel Fernández-Real; Paul Muntner; Eliseo Guallar
Journal:  BMC Cardiovasc Disord       Date:  2009-08-03       Impact factor: 2.298

10.  Abnormalities of vascular histology and collagen fiber configuration in patients with advanced chronic kidney disease.

Authors:  Michael Allon; Silvio H Litovsky; Jason Chieh Sheng Tey; Chad A Sundberg; Yingying Zhang; Zhen Chen; Yun Fang; Alfred K Cheung; Yan-Ting Shiu
Journal:  J Vasc Access       Date:  2018-05-09       Impact factor: 2.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.